APPLICATION OF THE DRUG "TRAUMEL WITH" U SICK WITH PURENT- INFLAMMATORY DISEASES MAXILLOFACIAL AREA
##plugins.themes.bootstrap3.article.main##
Abstrak:
Patients with purulent-inflammatory diseases of the maxillofacial area make up about 15-20 % of patients visiting dental clinics and more than 60% of patients receiving medical care in maxillofacial surgery departments . In patients hospitalized in departments with a diagnosis of abscess or phlegmon , there are from 35% to 70% of the total number of patients. According to various authors, from 30% to 40% of dental beds are for patients diagnosed with odontogenic osteomyelitis..
##plugins.themes.bootstrap3.article.details##
##submission.howToCite##:
Sadriev , N. ., Tilalov , H. ., Toshpoʻlatova , K., & Baxtiyorov , D. (2024). APPLICATION OF THE DRUG "TRAUMEL WITH" U SICK WITH PURENT- INFLAMMATORY DISEASES MAXILLOFACIAL AREA. Markaziy Osiyo Fanlararo Va Boshqaruv Tadqiqotlari Jurnali, 1(1), 55–58. Retrieved from https://in-academy.uz/index.php/cajmrms/article/view/27098
